About N-[2-[3-(dimethylamino)pyrrolidin-1-yl]-5-(trifluoromethyl)phenyl]-4-methyl-3-[[3-[2-(methylamino)pyrimidin-4-yl]-2-pyridinyl]oxy]benzamide
N-[2-[3-(dimethylamino)pyrrolidin-1-yl]-5-(trifluoromethyl)phenyl]-4-methyl-3-[[3-[2-(methylamino)pyrimidin-4-yl]-2-pyridinyl]oxy]benzamide (PubChem CID 66970269) has the molecular formula C31H32F3N7O2
and a molecular weight of 591.64 g/mol. Its IUPAC name is N-[2-[3-(dimethylamino)pyrrolidin-1-yl]-5-(trifluoromethyl)phenyl]-4-methyl-3-[[3-[2-(methylamino)pyrimidin-4-yl]-2-pyridinyl]oxy]benzamide.
Molecular Properties
| Compound Name | N-[2-[3-(dimethylamino)pyrrolidin-1-yl]-5-(trifluoromethyl)phenyl]-4-methyl-3-[[3-[2-(methylamino)pyrimidin-4-yl]-2-pyridinyl]oxy]benzamide |
| PubChem CID | 66970269 |
| Molecular Formula | C31H32F3N7O2 |
| Molecular Weight | 591.64 g/mol |
| Exact Mass | 591.26 |
| IUPAC Name | N-[2-[3-(dimethylamino)pyrrolidin-1-yl]-5-(trifluoromethyl)phenyl]-4-methyl-3-[[3-[2-(methylamino)pyrimidin-4-yl]-2-pyridinyl]oxy]benzamide |
| SMILES | CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCC(N(C)C)C3)ccc2C)n1 |
| InChI | InChI=1S/C31H32F3N7O2/c1-19-7-8-20(16-27(19)43-29-23(6-5-13-36-29)24-11-14-37-30(35-2)39-24)28(42)38-25-17-21(31(32,33)34)9-10-26(25)41-15-12-22(18-41)40(3)4/h5-11,13-14,16-17,22H,12,15,18H2,1-4H3,(H,38,42)(H,35,37,39) |
| InChIKey | DFDZQSVHLYOWRV-UHFFFAOYSA-N |
| XLogP | 6.09 |
| TPSA | 95.51 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 43 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 591.64 |
| LogP ≤ 5 | 6.09 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Analyze N-[2-[3-(dimethylamino)pyrrolidin-1-yl]-5-(trifluoromethyl)phenyl]-4-methyl-3-[[3-[2-(methylamino)pyrimidin-4-yl]-2-pyridinyl]oxy]benzamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[2-[3-(dimethylamino)pyrrolidin-1-yl]-5-(trifluoromethyl)phenyl]-4-methyl-3-[[3-[2-(methylamino)pyrimidin-4-yl]-2-pyridinyl]oxy]benzamide?
The IUPAC name of N-[2-[3-(dimethylamino)pyrrolidin-1-yl]-5-(trifluoromethyl)phenyl]-4-methyl-3-[[3-[2-(methylamino)pyrimidin-4-yl]-2-pyridinyl]oxy]benzamide (CID 66970269) is N-[2-[3-(dimethylamino)pyrrolidin-1-yl]-5-(trifluoromethyl)phenyl]-4-methyl-3-[[3-[2-(methylamino)pyrimidin-4-yl]-2-pyridinyl]oxy]benzamide.
What is the SMILES notation for N-[2-[3-(dimethylamino)pyrrolidin-1-yl]-5-(trifluoromethyl)phenyl]-4-methyl-3-[[3-[2-(methylamino)pyrimidin-4-yl]-2-pyridinyl]oxy]benzamide?
The canonical SMILES for N-[2-[3-(dimethylamino)pyrrolidin-1-yl]-5-(trifluoromethyl)phenyl]-4-methyl-3-[[3-[2-(methylamino)pyrimidin-4-yl]-2-pyridinyl]oxy]benzamide is CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cc(C(F)(F)F)ccc3N3CCC(N(C)C)C3)ccc2C)n1.
What is the InChIKey of N-[2-[3-(dimethylamino)pyrrolidin-1-yl]-5-(trifluoromethyl)phenyl]-4-methyl-3-[[3-[2-(methylamino)pyrimidin-4-yl]-2-pyridinyl]oxy]benzamide?
The InChIKey is DFDZQSVHLYOWRV-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H32F3N7O2/c1-19-7-8-20(16-27(19)43-29-23(6-5-13-36-29)24-11-14-37-30(35-2)39-24)28(42)38-25-17-21(31(32,33)34)9-10-26(25)41-15-12-22(18-41)40(3)4/h5-11,13-14,16-17,22H,12,15,18H2,1-4H3,(H,38,42)(H,35,37,39).
What are the key properties of N-[2-[3-(dimethylamino)pyrrolidin-1-yl]-5-(trifluoromethyl)phenyl]-4-methyl-3-[[3-[2-(methylamino)pyrimidin-4-yl]-2-pyridinyl]oxy]benzamide?
N-[2-[3-(dimethylamino)pyrrolidin-1-yl]-5-(trifluoromethyl)phenyl]-4-methyl-3-[[3-[2-(methylamino)pyrimidin-4-yl]-2-pyridinyl]oxy]benzamide has a molecular weight of 591.64 g/mol, XLogP of 6.09, 8 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[3-(dimethylamino)pyrrolidin-1-yl]-5-(trifluoromethyl)phenyl]-4-methyl-3-[[3-[2-(methylamino)pyrimidin-4-yl]-2-pyridinyl]oxy]benzamide is sourced from PubChem (CID 66970269), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).